Use of Everolimus in Liver Transplantation: Recommendations From a Working Group
Sign Up to like & getrecommendations! Published in 2017 at "Transplantation"
DOI: 10.1097/tp.0000000000001438
Abstract: AbstractImmunosuppression after liver transplantation (LT) is presently based on use of calcineurin inhibitors (CNI), although they are associated with an increased incidence of renal dysfunction, cardiovascular complications, and de novo and recurrent malignancies. Over the… read more here.
Keywords: use everolimus; use; group; evr ... See more keywords
Use of everolimus in advanced hormone receptor–positive metastatic breast cancer in a multicenter national observational study.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e12548
Abstract: e12548Background: The everolimus-exemestane combination has been included in the International guidelines for advanced HR+ breast cancer (mBC) since the results of the Bolero-2 trial. Marketing authorization has been granted in France in July 2012 and… read more here.
Keywords: use everolimus; use; everolimus advanced; breast cancer ... See more keywords